These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13598369)

  • 1. [The correct way to use combined antituberculosis drugs; on alpha-ethylisonicotinic acid thioamide, a new antituberculosis drug active against isoniazid-resistant bacteria].
    RIST N
    Hoja Tisiol; 1958 Sep; 18(3):171-82. PubMed ID: 13598369
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new antituberculotic drug active against isoniazid-resistant bacteria: alpha-ethylisonicotinic acid thioamide; experimental study].
    RIST N; GRUMBACH F; LIBERMANN D; MOYEUX M; CALS S; CLAVEL S
    Rev Tuberc; 1958; 22(2-3):278-83. PubMed ID: 13568469
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis treatment. A practical guide elaborated by the tuberculosis section, Argentine Association of Respiratory Medicine].
    Abbate EH; Palmero DJ; Castagnino J; Cufre M; Doval A; Estevan R; Kuriger A; Limongi L; Moraña E; Musella R; Pibida C; Putruele AM; Tanco S; Vescovo M;
    Medicina (B Aires); 2007; 67(3):295-305. PubMed ID: 17628921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis.
    Thwaites GE; Lan NT; Dung NH; Quy HT; Oanh DT; Thoa NT; Hien NQ; Thuc NT; Hai NN; Bang ND; Lan NN; Duc NH; Tuan VN; Hiep CH; Chau TT; Mai PP; Dung NT; Stepniewska K; White NJ; Hien TT; Farrar JJ
    J Infect Dis; 2005 Jul; 192(1):79-88. PubMed ID: 15942897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
    Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new antituberculous drug, alpha-ethylisonicotinic thioamide or 1314 Th; experimental basis for its clinical use].
    GRUMBACH F; LIBERMANN D
    Presse Med (1893); 1959 Mar; 67(16):625-6. PubMed ID: 13645500
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary and acquired resistance to antituberculous drugs in strains of Mycobacterium tuberculosis isolated in Rwanda].
    Umubyeyi AN; Rigouts L; Zissis G; Kamanzi E; Pauwels P; Gasana M; Vandebriel G; Struelens M; Portaels F
    Med Trop (Mars); 2007 Apr; 67(2):149-53. PubMed ID: 17691433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical results of treatment of pulmonary tuberculosis by methyl antigen in combination with antituberculosis drugs].
    DONOMAE I; IWASAKI T; KAIDA K; KAWAMORI Y; KITAMOTO O; SHINOHARA K
    Poumon Coeur; 1961 Jan; 17():51-8. PubMed ID: 13723792
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary reports on the activity of alpha-ethylisonicotic thioamide in pulmonary tuberculosis].
    DESMEULES R; DION R; MOISAN F; TURMEL C
    Laval Med; 1959 Jun; 28(1):42-9. PubMed ID: 13666059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pneumoconiosis and mycobacterial infection].
    Kekkaku; 2003 Nov; 78(11):711-5. PubMed ID: 14672049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
    Karabay O; Otkun M; Akata F; Karlikaya C; Tuğrul M; Dündar V
    Indian J Chest Dis Allied Sci; 2004; 46(3):171-7. PubMed ID: 15553205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multidrug resistant tuberculosis: what is the risk in france?].
    Bouvet E
    Rev Prat; 2007 Sep; 57(13):1405-8. PubMed ID: 18018538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.
    Tsai MS; Chong IW; Hwang JJ; Wang TH; Huang MS
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):136-9. PubMed ID: 15272756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.